Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The CDK8 kinase module: A novel player in the transcription of translation initiation and ribosomal genes. | Mol Biol Cell | 2025 | 39565680 | PubTator, text mining | PubMed |
| Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing. | Cell Death Differ | 2025 | 39425000 | PubTator, text mining | PubMed |
| Assessment of iridoids and their similar structures as antineoplastic drugs by in silico approach. | J Biomol Struct Dyn | 2025 | 38345021 | PubTator, text mining | PubMed |
| A Novel Series of Coumarin Derivatives That Exert Osteoblastogenic Effects in Mesenchymal Stem Cells and Osteogenic Effects in Ovariectomized Female Rats. | Chem Pharm Bull (Tokyo) | 2024 | 39721699 | PubTator, text mining | PubMed |
| Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantation. | Front Microbiol | 2024 | 39619695 | PubTator, text mining | PubMed |
| Author Correction: NOTCH localizes to mitochondria through the TBC1D15-FIS1 interaction and is stabilized via blockade of E3 ligase and CDK8 recruitment to reprogram tumor-initiating cells. | Exp Mol Med | 2024 | 39465353 | PubTator, text mining | PubMed |
| CDK8/19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes. | Br J Haematol | 2024 | 39413769 | PubTator, text mining | PubMed |
| Special Issue: "Molecular Dynamics Simulations and Structural Analysis of Protein Domains". | Int J Mol Sci | 2024 | 39409122 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of a Novel Series of Diphenylamine and Diphenylether Derivatives with Osteoblastogenic and Osteogenic Effects via CDK8 Inhibition. | Chem Pharm Bull (Tokyo) | 2024 | 39370261 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies. | Pharmaceutics | 2024 | 39339274 | PubTator, text mining | PubMed |
| Structural basis of the human transcriptional Mediator regulated by its dissociable kinase module. | Mol Cell | 2024 | 39321804 | PubTator, text mining | PubMed |
| Pediatric Angiosarcoma with Novel Phenotypic and Genotypic Profile in Chinese Children. | Fetal Pediatr Pathol | 2024 | 39269732 | PubTator, text mining | PubMed |
| MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer. | Endocrinology | 2024 | 39253786 | PubTator, text mining | PubMed |
| An intrinsically disordered region in MED13 turns Mediator on/off on cue. | Mol Cell | 2024 | 39178836 | PubTator, text mining | PubMed |
| Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas. | Front Pharmacol | 2024 | 39170701 | PubTator, text mining | PubMed |
| Design and synthesis of 7-azaindole derivatives as potent CDK8 inhibitors for the treatment of acute myeloid leukemia. | RSC Med Chem | 2024 | 39157854 | PubTator, text mining | PubMed |
| Enriching Anticancer Drug Pipeline with Potential Inhibitors of Cyclin-Dependent Kinase-8 Identified from Natural Products. | OMICS | 2024 | 39149808 | PubTator, text mining | PubMed |
| Case report: Precision guided reactive cancer management: molecular complete response in heavily pretreated metastatic CRC by dual immunotherapy and sorafenib. | Front Oncol | 2024 | 39011472 | PubTator, text mining | PubMed |
| Structural basis of the human transcriptional Mediator complex modulated by its dissociable Kinase module. | bioRxiv | 2024 | 39005267 | PubTator, text mining | PubMed |
| RETRACTION: LINC01224 accelerates malignant transformation via MiR-193a-5p/CDK8 axis in gastric cancer. | Cancer Med | 2024 | 38813645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=6